School of Physical Education and Health, Chengdu University of Traditional Chinese Medicine, Wenjiang District, Chengdu, Sichuan Province, China.
Faculty of Physical Culture, Gdansk University of Physical Education and Sport, Poland, Gdańsk, Poland.
Medicine (Baltimore). 2023 Apr 7;102(14):e33147. doi: 10.1097/MD.0000000000033147.
nonalcoholic fatty liver disease (NAFLD) is characterized by excessive accumulation of fat in the liver without alcoholism. We conducted a systematic review and meta-analysis to elucidate the efficacy of aerobic exercise on metabolic indicators and physical performance of adult patients with NAFLD.
To conduct the systematic review and network meta-analysis, 2 researchers searched PubMed, EBSCO, and Web of science databases to identify randomized clinical trials of aerobic exercise interventions for adults with NAFLD published between inception and July 2022. We assessed the methodological quality of the included literature using the Cochrane Risk Assessment Scale and the PEDro Scale. Relevant data were extracted, variables were converted to the same units, and meta-analysis was performed using RevMan 5.4 software. We compared mean differences (MD) between experimental and control groups. For each outcome analyzed, we expressed data as MD with 95% CI to compare metabolic markers and exercise capacity between the experimental and control NAFLD patients.
Eleven randomized clinical trials with a total of 491 individuals with NAFLD were included in accordance with the criteria of this study. Types of aerobic exercise include moderate or high-intensity interval running, cycling, Nordic walking, equipment training, etc; Training duration 4 to 16 weeks, 30 to 60 minutes 3 or more times a week. Compared with the control group, aerobic exercise group had reduced weight of patients, (MD) 1.20 kg (95% CI: -1.38 to -1.01 kg, P < .00001). Seven studies confirmed that aerobic exercise significantly reduced triglycerides, (MD) 3.00 mg/dL (95% CI: -5.80 to -0.21 mg/dL, P = .04); increased high density lipoproteins (MD) 5.96 mg/dL (95% CI: 2.95 to 8.96 mg/dL, P = .0001) and reduced low-density lipoproteins (MD) 6.45 mg/dL (95% CI: -8.53 to -4.37 mg/dL, P < .00001); the study also showed that aerobic exercise reduced the liver enzymes aspartate aminotransferase and alanine aminotransferase to varying degrees. Aerobic exercise can improve physical performance and increase peak oxygen consumption of (MD) 6.29 mL/Kgminutes, (95% CI: 3.05-9.53mL/Kgminutes, P = .0001).
Aerobic exercise significantly reduced weight and improved metabolic index and physical performance. Impacted by the limitations of various regimens, doses, duration, center settings, populations enrolled, the study had certain limitations. The randomized controlled trials with larger sample sizes, multiple centers, and high quality should be conducted to validate the above conclusion. Further studies will be required to focus on the total duration of the intervention, duration and frequency of sessions, and intensity that are optimal for the promotion of physical performance and metabolic capacity in this population.
非酒精性脂肪性肝病(NAFLD)的特征是肝脏脂肪堆积过多而无酗酒。我们进行了一项系统评价和荟萃分析,以阐明有氧运动对成年 NAFLD 患者代谢指标和身体表现的疗效。
为了进行系统评价和网络荟萃分析,两名研究人员检索了 PubMed、EBSCO 和 Web of Science 数据库,以确定截至 2022 年 7 月发表的针对成人 NAFLD 的有氧运动干预的随机临床试验。我们使用 Cochrane 风险评估量表和 PEDro 量表评估纳入文献的方法学质量。提取相关数据,将变量转换为相同单位,并使用 RevMan 5.4 软件进行荟萃分析。我们比较了实验组和对照组之间的均数差异(MD)。对于每个分析的结果,我们以 MD 表示 95%CI,以比较实验和对照 NAFLD 患者的代谢标志物和运动能力。
根据本研究的标准,共有 11 项随机临床试验,共 491 名 NAFLD 患者纳入符合条件。有氧运动的类型包括中高强度间歇跑、骑自行车、北欧行走、设备训练等;训练持续时间为 4 至 16 周,每周 3 至 60 分钟 3 次以上。与对照组相比,有氧运动组患者体重减轻,(MD)1.20kg(95%CI:-1.38 至-1.01kg,P<0.00001)。7 项研究证实,有氧运动显著降低甘油三酯,(MD)3.00mg/dL(95%CI:-5.80 至-0.21mg/dL,P=0.04);增加高密度脂蛋白(MD)5.96mg/dL(95%CI:2.95 至 8.96mg/dL,P=0.0001)和降低低密度脂蛋白(MD)6.45mg/dL(95%CI:-8.53 至-4.37mg/dL,P<0.00001);研究还表明,有氧运动在不同程度上降低了天冬氨酸转氨酶和丙氨酸转氨酶等肝酶。有氧运动可以改善身体表现,增加(MD)6.29mL/Kgmin 的峰值耗氧量,(95%CI:3.05-9.53mL/Kgmin,P=0.0001)。
有氧运动可显著减轻体重,改善代谢指标和身体表现。受各种方案、剂量、持续时间、中心设置、入组人群的限制,研究存在一定的局限性。应开展更多具有更大样本量、多中心和高质量的随机对照试验,以验证上述结论。需要进一步研究,重点关注对该人群运动表现和代谢能力的促进作用的总干预持续时间、疗程和频率以及强度。